Ascorbic acid has been widely used, not only to induce differentiation of MC3T3-E1 cells [47], but is also known to inhibit RANKL-induced osteoclastogenesis of RAW264.7 cells at higher doses [48], which is promising as a potential nutritional vitamin for osteoporosis therapy [49]. This evidence concerns the gene TNFSF11 and osteoporosis.